American Vanguard Corp. (AVD) has been getting punished recently because of its poor showing in the last quarter, where revenue was down, earnings missed, and operating expenses soared.
This isn't too worrisome, as it's the nature of a company serving the agriculture segment to sometimes experience these types of results because of weather and farmers cutting back on spending on certain crops.
Fortunately, it looks like the second half of 2013 will be much better, with sales of Metam, Bidrin, Dibrom, Vapam, and Folex expected to rise because of various conditions conducive to those products, including weather and pests.
Over the longer term its Impact herbicide and equity investment in life sciences company TyraTech, Inc. could drive sales...
Only subscribers can access this article, which is part of the PRO research library covering 3,587 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: